batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. A new kid on the radiopharma block 9 January 2024 Scemblix hits the front line 8 January 2024 Caribou keeps the faith 8 January 2024 Cellectar makes its radiopharma pitch 8 January 2024 ASCO-GI preview: notable late-breakers 5 January 2024 Lacutamab lift boosts Innate 4 January 2024 First 2024 deals pick up where 2023 left off 2 January 2024 Sanofi switches to another CEACAM5 asset 21 December 2023 Load More